🔗 Share this article

Chancellor Rachel Reeves has revealed she is planning "targeted steps to tackle household expense pressures" in the upcoming Budget.

During an interview with media outlets, she emphasized that reducing price rises is a shared responsibility of both the administration and the central bank.

The United Kingdom's inflation rate is forecast to be the most elevated among the Group of Seven industrialized countries this year and next.

Possible Utility Cost Measures

Sources suggest the administration could take action to reduce utility costs, such as by reducing the present 5% rate of VAT charged on energy supplies.

Another option is to lower some of the regulatory levies currently added to household expenses.

Budgetary Limitations and Expert Expectations

The administration will obtain the latest assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much scope there is for such actions.

The expectation from the majority of experts is that the Chancellor will have to declare tax increases or spending cuts in order to meet her voluntary fiscal targets.

Previously on Thursday, estimates indicated there was a £22bn deficit for the chancellor to fill, which is at the more modest range of projections.

"There's a collective task between the central bank and the government to continue tackling some of the causes of price increases," the Chancellor stated to reporters in Washington, at the annual meetings of the International Monetary Fund and World Bank.

Tax Commitments and International Issues

While a great deal of the focus has been on probable tax increases, the chancellor said the latest figures from the OBR had not altered her pledge to manifesto promises not to increase rates on earnings tax, VAT or National Insurance.

She blamed an "unpredictable world" with growing geopolitical and trade issues for the Budget tax moves, likely to be targeted on those "most able to pay."

International Trade Disputes

Commenting on concerns about the United Kingdom's trade ties with China she said: "Our security interests invariably are paramount."

Last week's declaration by China to increase trade restrictions on rare earths and other resources that are essential for advanced tech manufacturing led US President Donald Trump to threaten an additional 100% import tax on imports from China, increasing the risk of an all-out trade war between the two global powers.

The US Treasury Secretary labeled China's decision "commercial pressure" and "a international production power grab."

Questioned on considering the US offer to join its conflict with the Asian nation, Reeves said she was "deeply worried" by China's actions and called on the Chinese government "to avoid restrictions and restrict access."

She said the decision was "harmful for the global economy and creates further obstacles."

"It is my opinion there are areas where we should confront China, but there are also important opportunities to sell into China's economy, including financial services and other areas of the economy. We've got to get that equilibrium correct."

The chancellor also confirmed she was collaborating with G7 counterparts "regarding our own essential resources strategy, so that we are less reliant."

NHS Drug Costs and Investment

The Chancellor also admitted that the cost the NHS spends on drugs could rise as a consequence of current talks with the Trump administration and its pharmaceutical firms, in return for lower tariffs and investment.

A number of the biggest global drug companies have said in recent statements that they are either halting or abandoning investments in the UK, with several attributing the low prices they are obtaining.

Last month, the government science advisor said the price the health service pays for drugs would have to go up to stop businesses and pharmaceutical investment departing from the UK.

Reeves stated to media: "It has been observed as a result of the payment system, that drug testing, innovative medicines have not been provided in the United Kingdom in the way that they are in other European countries."

"The objective is to guarantee that individuals getting care from the National Health Service are can access the best life-saving drugs in the world. And so we are reviewing all of that, and... looking to attract additional capital into the UK."